These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29023579)

  • 1. Role of the N-terminus for the stability of an amyloid-β fibril with three-fold symmetry.
    Söldner CA; Sticht H; Horn AHC
    PLoS One; 2017; 12(10):e0186347. PubMed ID: 29023579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the lack of polymorphism in Aβ-peptide aggregates derived from patient brains.
    Alred EJ; Phillips M; Berhanu WM; Hansmann UH
    Protein Sci; 2015 Jun; 24(6):923-35. PubMed ID: 25739352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkali ion influence on structure and stability of fibrillar amyloid-β oligomers.
    Huraskin D; Horn AHC
    J Mol Model; 2019 Jan; 25(2):37. PubMed ID: 30637529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micelle-like architecture of the monomer ensemble of Alzheimer's amyloid-β peptide in aqueous solution and its implications for Aβ aggregation.
    Vitalis A; Caflisch A
    J Mol Biol; 2010 Oct; 403(1):148-165. PubMed ID: 20709081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
    Dong M; Zhao W; Hu D; Ai H; Kang B
    ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural features of the Abeta amyloid fibril elucidated by limited proteolysis.
    Kheterpal I; Williams A; Murphy C; Bledsoe B; Wetzel R
    Biochemistry; 2001 Oct; 40(39):11757-67. PubMed ID: 11570876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations to investigate the aggregation behaviors of the Abeta(17-42) oligomers.
    Zhao JH; Liu HL; Liu YF; Lin HY; Fang HW; Ho Y; Tsai WB
    J Biomol Struct Dyn; 2009 Feb; 26(4):481-90. PubMed ID: 19108587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response to fibrillar beta-amyloid peptide.
    Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
    Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Stabilizing Forces in Amyloid Fibrils of Differing Sizes from Polarizable Molecular Dynamics Simulations.
    Davidson DS; Brown AM; Lemkul JA
    J Mol Biol; 2018 Oct; 430(20):3819-3834. PubMed ID: 29782833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
    Andarzi Gargari S; Barzegar A; Tarinejad A
    PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2-microglobulin amyloid fragment organization and morphology and its comparison to Abeta suggests that amyloid aggregation pathways are sequence specific.
    Zheng J; Jang H; Nussinov R
    Biochemistry; 2008 Feb; 47(8):2497-509. PubMed ID: 18215070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
    König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
    J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in understanding Alzheimer's β-amyloid structures.
    Fändrich M; Schmidt M; Grigorieff N
    Trends Biochem Sci; 2011 Jun; 36(6):338-45. PubMed ID: 21411326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
    Sun Y; Qian Z; Wei G
    Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid Fibril Design: Limiting Structural Polymorphism in Alzheimer's Aβ Protofilaments.
    Tywoniuk B; Yuan Y; McCartan S; Szydłowska BM; Tofoleanu F; Brooks BR; Buchete NV
    J Phys Chem B; 2018 Dec; 122(49):11535-11545. PubMed ID: 30335383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational stability of fibrillar amyloid-beta oligomers via protofilament pair formation - a systematic computational study.
    Kahler A; Sticht H; Horn AH
    PLoS One; 2013; 8(7):e70521. PubMed ID: 23936224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
    Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
    Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.